Open-Label Access to ATH434 for Patients Who Completed Study ATH434-201 in France

NCT07729852 · clinicaltrials.gov ↗

PHASE2

Phase

ENROLLING_BY_INVITATION

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple System Atrophy

Interventions

DRUG: ATH434

Sponsor

Alterity Therapeutics